The value of environmental surveillance for pandemic response

Environmental sampling surveillance (ESS) technologies, such as wastewater genomic surveillance and air sensors, have been increasingly adopted during the COVID-19 pandemic to provide valuable information for public health response. However, ESS coverage is not universal, and public health decision-makers need support to choose whether and how to expand and sustain ESS efforts. This paper introduces a model and approach to quantify the value of ESS systems that provide leading epidemiological indicators for pandemic response. Using the COVID-19 pandemic as a base-case scenario, we quantify the value of ESS systems in the first year of a new pandemic and demonstrate how the value of ESS systems depends on biological and societal parameters. Under baseline assumptions, an ESS system that provides a 5-day early warning relative to syndromic surveillance could reduce deaths from 149 (95% prediction interval: 136-169) to 134 (124-144) per 100,000 population during the first year of a new COVID-19-like pandemic, resulting in a net monetary benefit of $1,450 ($609-$2,740) per person. The system's value is higher for more transmissible and deadly pathogens but hinges on the effectiveness of public health interventions. Our findings also suggest that ESS systems would provide net-positive benefits even if they were permanently maintained and pathogens like SARS-Cov-2 emerged once every century or less frequently. Our results can be used to prioritize pathogens for ESS, decide whether and how to expand systems to currently uncovered populations, and determine how to scale surveillance systems' coverage over time.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2024-11-22
DOI
https://doi.org/10.1038/s41598-024-79952-5
Citations
4
Primary Topic
SARS-CoV-2 detection and testing
Type
article
Field-Weighted Citation Impact
1.56

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The value of environmental surveillance for pandemic response

Raffaele Vardavas, Derek Roberts, Jing Zhi Lim, Henry H. Willis et al.
4 citations
Scientific Reports
SARS-CoV-2 detection and testing
1.56
article

The value of environmental surveillance for pandemic response

Raffaele Vardavas, Derek Roberts, Jing Zhi Lim, Henry H. Willis, Stephen L. Karr, Laura J. Faherty, Jalal Awan, Pedro Nascimento de Lima, Anne Kessler
article en
4 citations

Abstract

Environmental sampling surveillance (ESS) technologies, such as wastewater genomic surveillance and air sensors, have been increasingly adopted during the COVID-19 pandemic to provide valuable information for public health response. However, ESS coverage is not universal, and public health decision-makers need support to choose whether and how to expand and sustain ESS efforts. This paper introduces a model and approach to quantify the value of ESS systems that provide leading epidemiological indicators for pandemic response. Using the COVID-19 pandemic as a base-case scenario, we quantify the value of ESS systems in the first year of a new pandemic and demonstrate how the value of ESS systems depends on biological and societal parameters. Under baseline assumptions, an ESS system that provides a 5-day early warning relative to syndromic surveillance could reduce deaths from 149 (95% prediction interval: 136-169) to 134 (124-144) per 100,000 population during the first year of a new COVID-19-like pandemic, resulting in a net monetary benefit of $1,450 ($609-$2,740) per person. The system's value is higher for more transmissible and deadly pathogens but hinges on the effectiveness of public health interventions. Our findings also suggest that ESS systems would provide net-positive benefits even if they were permanently maintained and pathogens like SARS-Cov-2 emerged once every century or less frequently. Our results can be used to prioritize pathogens for ESS, decide whether and how to expand systems to currently uncovered populations, and determine how to scale surveillance systems' coverage over time.

Scientific ReportsVol. 14(1)
Tufts University (US), RAND Corporation (US), Maine Medical Center (US)
RAND Corporation, National Institutes of Health
Good health and well-being
Openalex Percentile: Top 16%
SARS-CoV-2 detection and testing
1.56
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.